Dr. Bradley J. Abrams is a dermatologist in Sarasota,Florida. He graduated from Kirksville College of Osteopathic Medicine in 1994 and has been in practice for 28 years.
Male
1316901895
Description | # of Times Performed | # of Patients | Average Charge ($) |
---|---|---|---|
Tangential biopsy of single skin lesion | 618.0 | 493.0 | 197.04 |
Tangential biopsy of additional skin lesion | 222.0 | 157.0 | 106.4 |
Punch biopsy of single skin lesion | 26.0 | 25.0 | 247.62 |
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 38.0 | 32.0 | 502.24 |
Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | 23.0 | 21.0 | 576.1 |
Injection of up to 7 skin growths | 31.0 | 28.0 | 109.52 |
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 14.0 | 14.0 | 613.38 |
Repair of wound (2.6 to 7.5 centimeters) of trunk | 22.0 | 22.0 | 808.9 |
Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | 52.0 | 47.0 | 872.36 |
Repair of wound of scalp, arms, and/or legs | 14.0 | 13.0 | 271.38 |
Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 26.0 | 23.0 | 960.64038462 |
Tissue transfer repair of wound (10 sq centimeters or less) of the scalp, arms, and/or legs | 11.0 | 11.0 | 1422.08 |
Tissue transfer repair of wound (10 sq centimeters or less) of the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 64.0 | 56.0 | 1555.94 |
Tissue transfer repair of wound (10.1 to 30.0 sq centimeters) of the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 18.0 | 18.0 | 1921.0 |
Tissue transfer repair of wound (10 sq centimeters or less) of eyelids, nose, ears, and/or lips | 25.0 | 25.0 | 1588.3 |
Relocation of patient skin to nose, ears, eyelids, and/or lips (20 sq centimeters or less) | 12.0 | 12.0 | 2071.42 |
Destruction of skin growth | 727.0 | 514.0 | 131.4 |
Destruction of 2-14 skin growths | 1925.0 | 393.0 | 11.4 |
Destruction of up to 14 skin growths | 40.0 | 32.0 | 219.84 |
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | 47.0 | 43.0 | 291.22 |
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 44.0 | 39.0 | 356.14 |
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 178.0 | 140.0 | 1351.04 |
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | 98.0 | 78.0 | 798.4 |
Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | 16.0 | 14.0 | 1261.2 |
Biopsy of ear | 32.0 | 31.0 | 197.46 |
Pathology examination of tissue using a microscope, intermediate complexity | 64.0 | 46.0 | 137.28 |
Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per day | 26.0 | 26.0 | 369.74 |
Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day | 50.0 | 44.0 | 477.46 |
Removal of tissue from wounds per session | 34.0 | 21.0 | 175.26 |
New patient office or other outpatient visit, typically 20 minutes | 110.0 | 110.0 | 153.08 |
New patient office or other outpatient visit, typically 30 minutes | 198.0 | 198.0 | 218.3 |
Established patient office or other outpatient visit, typically 5 minutes | 34.0 | 32.0 | 44.84 |
Established patient office or other outpatient visit, typically 10 minutes | 273.0 | 224.0 | 89.98 |
Established patient office or other outpatient visit, typically 15 minutes | 1030.0 | 729.0 | 148.82 |
Established patient office or other outpatient, visit typically 25 minutes | 278.0 | 260.0 | 218.08 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42.0 | 22.0 | 3.2523809524 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 82.0 | 71.0 | 797.44670732 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.